Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Aliment Pharmacol Ther. 2020 Aug 8;52(6):976–987. doi: 10.1111/apt.16013

TABLE 2.

Urinary prostaglandin E metabolite (PGE-M) adjusted for creatinine [mean (standard deviation)] before and after treatment in the aspirin and placebo arm. [Correction added on August 28, 2020 after first online publication: The 1st column heading was revised.]

Time of sample collection Aspirin Placebo P-value
PGE-Ma per creatinine, ng/mg Before treatment 12.29 (13.82) 12.94 (7.39) 0.74
After treatment 6.38 (4.77) 13.30 (6.63) 0.001
Change after treatment −5.91 (11.15) 0.36 (6.98) 0.07
a

PGE-M - metabolite of prostaglandin E2.